Cargando…
Pterostilbene-Isothiocyanate Conjugate Suppresses Growth of Prostate Cancer Cells Irrespective of Androgen Receptor Status
Chemotherapy and anti-hormonal therapies are the most common treatments for non-organ-confined prostate cancer (PCa). However, the effectiveness of these therapies is limited, thus necessitating the development of alternative approaches. The present study focused on analyzing the role of pterostilbe...
Autores principales: | Nikhil, Kumar, Sharan, Shruti, Chakraborty, Ajanta, Roy, Partha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974779/ https://www.ncbi.nlm.nih.gov/pubmed/24699278 http://dx.doi.org/10.1371/journal.pone.0093335 |
Ejemplares similares
-
Anticancer Activities of Pterostilbene-Isothiocyanate Conjugate in Breast Cancer Cells: Involvement of PPARγ
por: Nikhil, Kumar, et al.
Publicado: (2014) -
Pterostilbene-Isothiocyanate Inhibits Proliferation
of Human MG-63 Osteosarcoma Cells via Abrogating β-Catenin/TCF-4
Interaction—A Mechanistic Insight
por: Kumar, Viney, et al.
Publicado: (2023) -
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression
por: HE, SUQIN, et al.
Publicado: (2012) -
Effects of Brassicaceae Isothiocyanates on Prostate Cancer
por: Novío, Silvia, et al.
Publicado: (2016) -
The development and characterisation of porphyrin isothiocyanate–monoclonal antibody conjugates for photoimmunotherapy
por: Hudson, R, et al.
Publicado: (2005)